Inhibition of Bioprosthesis Calcification Due to Synergistic Effect of Fe/Mg Ions to Polyethylene Glycol Grafted Bovine Pericardium

Abstract

Calcification has limited the durability of bioprosthetic heart valves fabricated from glutaraldehyde pretreated porcine aortic valves or bovine pericardium (BP). The present study describes calcium antagonistic effect of polyethylene glycol grafted bovine pericardium (PEG-GABP) with Fe²⁺/Mg²⁺ delivery from a co-matrix system in rat subcutaneous model. Retrieved samples were biochemically evaluated for calcification and alkaline phosphate (AP) activity. Scanning electron micrographs of 21-day explants had shown excessive calcification with glutaraldehyde treated BP (control). However, the PEG grafting and Fe/Mg release had substantially inhibited the deposition of calcium on BP. The extractable alkaline phosphatase activity was also reduced with PEG grafting and metal ion release to BP. The extractable AP had shown peak activity at 72 h [for GATBP—250.5 ± 1.2 nm pnp/mg protein/min enzyme activity (unit), PEG-GABP—165.2 ± 16.6 units], but markedly reduced after 21 days (22.1 ± 1.8 and 12.0 ± 1.5 units, respectively). The initial high levels may be due to tissue injury via surgery, which mitigated with time. It is assumed that ferric ions may slow down or retard the calcification process by the inhibition of proper formation of hydroxy apatite while magnesium ions disrupt the growth of these crystals by replacing Ca²⁺. In addition it may be hypothesized that these metal ions may inhibit the key element alkaline phosphatase, which acts as the substrate for mineralization. Hence, it is conceivable that a combination therapy via surface grafting of PEG and local delivery of low levels of ferric and magnesium ions may prevent the bioprosthesis associated calcification.

Keywords

calcification alkaline phosphatase bovine pericardium Fe/Mg delivery polyethylene glycol

Get full access to this article

View all access options for this article.

References

1. Levy, R.J. , Schoen F.J. and Golomb G. 1986. “Bioprosthetic heart valve calcification: Clinical features, pathobiology and prospects for prevention”, CRC Crit. Rev. Biocompat., 2: 147–187.

2. Levy, R.J. , Schoen F.J. and Levy, J.T. 1983. “Biological determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde preserved porcine aortic valves leaflets implanted subcutaneously in rats”, Am. J. Pathol., 113: 1143–1155.

3. Golomb G. , Schoen F.J. , Smith M.S. , et al. 1987. “The role of glutaraldehyde induced crosslinks in calcification of bovine pericardium used in cardiac valve bioprosthesis”, Am. J. Pathol. 127: 122–130.

4. Nose Y. , Harasaki H. and Murray J. 1981. “Mineralization of artificial surfaces that contact blood”, Trans. Am. Soc. Artif. Intern. Organs., 27: 714–720.

5. Anderson, H.C. 1981. “Normal and abnormal mineralization in mammals”, Trans. Am. Soc. Artif. Intern. Organs., 27: 702–708.

6. Levy, R.J. , Schoen, F.J. , Flowers, W.B. and Staelin, S.T. 1991. “Inhibition of mineralization in bioprosthetic heart valves: Studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 pre-incubation”, J. Biomed. Mater. Res., 25: 905–935.

7. Golomb, G. and Ezara, V. 1991. “Prevention of bioprosthetic heart tissue calcification effects of protamine binding by formaldehyde.” J. Biomed. Mater. Res., 25: 85–98.

8. Webb, C.L. , Schoen, F.J. , Flowers, W.E. , Alfrey, A.C. , Horton, C. and Levy, R.J. 1991. “Inhibition of mineralization of glutaraldehyde pretreated bovine pericardium by AlCl3”, Am. J. Pathol., 138: 971–981.

9. Pathak, Y.B. , Boyd, J. and Levy, R.J. 1990. “Prevention of calcification of glutaraldehyde treated bovine pericardium through controlled release polymeric implants studies of Fe3+, Al3+, protamine sulphate and levamisole”, Biomaterials, 11: 718–723.

10.

10. Golomb, G. 1987. “Controlled release of diphosphonates from synthetic polymers to inhibit calcification.” J. Biomater., Appl., 2: 266–289.

11.

11. Chandy, T. , Ajith, Kumar B. and Sharma, C.P. 1994. “Inhibition of in vitro calcium phosphate precipitate in the presence of polyurethane via surface modification and drug delivery”, J. Appl. Biomater., 5: 245–254.

12.

12. Chandy, T. , Mohanty, M. , John, A. , Rao, S.B. , Sivakumar, R. , Sharma, C.P. and Valiathan, M.S. 1996. “Structural studies on bovine bioprosthetic tissue and their in vivo calcification prevention via drug delivery”, Biomaterials, 17(6): 577–586.

13.

13. Chandy, T. and Sharma, C.P. 1994. “Anesthetic and ferric magnesium ion combination as calcium antagonists for glutaraldehyde treated pericardial treated tissues”, Clinical Materials, 17: 165–172.

14.

14. Vasudev, S.C. and Chandy T. 1999. “Controlled release of ferric-magnesium ions from chitosan/polyethylene vinyl acetate co-matrix for preventing pericardial calcification”, Drug Delivery, 6: 117–126.

15.

15. Vasudev, S.C. and Chandy, T. 1997. “Effect of alternative crosslinking technique on the enzymatic degradation of bovine pericardium and their calcification”, J. Biomed. Mater. Res., 35: 357–369.

16.

16. Pasquino, E. , Pascale, S. , Anderson, M. , Pinaldi, S. , Laborde, F. and Galloni, M. 1992. “Bovine pericardium for heart valve bioprostheses in vitro and in vivo characterization of new chemical treatments”, J. Mater. Sci. Mater. Med., 3: 272–277.

17.

17. Courtman, D.W. , Pereira, C.A. , Kashef, V. , McComb, D. , Lee, J.M. and Wilson, G.J. 1994. “Development of a pericardial acellular matrix biomaterial, biochemical and mechanical effects of cell extraction”, J. Biomed. Mater. Res., 28: 655–666.

18.

18. Vasudev, S.C. , Chandy, T. and Sharma, C.P. 1997. “Development of chitosan/polyethylene vinyl acetate co-matrix controlled release of aspirin-heparin for preventing thrombosis”, Biomaterials, 18(5): 375–381.

19.

19. Lowry, O.H. , Rosebrough, N.O. and Farr, A.L. 1951. “Protein measurement with the folin phenol reagent”, J. Biol. Chem., 193: 265–275.

20.

20. Boucci, E. and Sadum R. 1994. “Experimental calcification of myocardium, ultrastructural and histochemical investigations”, Am. J. Pathol., 71: 167–192.

21.

21. Sheuer, P.J. and Chalk, B.T. 1986. Clinical Tests Histopathology, published by Wolfe Medical Publications Ltd., 120–120, 84–85.

22.

22. Merril, E.W. and Salzman, E.W. 1983. “Polyethylene oxide as a biomaterial”, 6(2): 60–64.

23.

23. Vroman, L. , Adams, A. , Klings, M. , Fisher, C. , Munos, P. and Solensky, R. 1977. “Reaction of formed elements of blood with plasma proteins at interfaces”, Ann. NY Acad. Sci., 283: 65–76.

24.

24. Goldstein, S. and Zstoer, T.T. 1978. “The effect of magnesium on the response of smooth muscle to 5-hydroxy–tryptamine”, Br. J. Pharmaco., 62: 507-507

25.

25. Tan, W.M. , Loke, W.M. , Tan, B.L. , Wee, H. , Khor, E. and Gon, K.S. 1993. “Trivalent metal ions in the prevention of calcification in the glutaraldehyde treated biological tissues: Is there a chemical correlation?”, Biomaterial, 14: 1003–1007.

26.

26. Blumenthal, N.C. 1989. “Mechanism of inhibition of calcification”, Clin. Orthop. Rel. Res., 27: 279–289.